Skip to main content

What the FDA labels say about taking them together

Fosamprenavir and nelfinavir

Fosamprenavir's FDA label of September 15, 2023 names nelfinavir in its drug interactions section; the nelfinavir label PlainMeds reads does not name fosamprenavir.

Check it at the source: the fosamprenavir FDA label on DailyMed (effective September 15, 2023, Mylan Pharmaceuticals Inc.); the nelfinavir FDA label on DailyMed (effective December 11, 2025, AGOURON).

What does the fosamprenavir label say about nelfinavir?

Fosamprenavir label, drug interactions

Concomitant Drug Class/Drug Name: HIV protease inhibitors: Indinavir, nelfinavir; Effect on Concentration of Amprenavir or Concomitant Drug: Fosamprenavir: ↑ Amprenavir Effect on indinavir and nelfinavir is not well established. Fosamprenavir/ ritonavir: Interaction has not been evaluated.; Clinical Comment: Appropriate doses of the combinations with respect to safety and efficacy have not been established.

Source: FDA drug label (Fosamprenavir Calcium), Mylan Pharmaceuticals Inc., effective September 15, 2023 (SPL set 3a1424d8-844c-4e24-9ebd-b2c2b61b61a3), via openFDA; the full label on DailyMed

What does the nelfinavir label say about fosamprenavir?

Nelfinavir's label (effective December 11, 2025) does not name fosamprenavir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (VIRACEPT), AGOURON, effective December 11, 2025 (SPL set e72c2bc6-9462-4a2e-8e1d-b97592376cbd), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

2Fosamprenavir generic labelers
0Nelfinavir generic labelers
FosamprenavirNelfinavir
Labeled forHIVHIV
Boxed warningNoNo
Pharmacy cost (NADAC)n/an/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?